References
- Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 1991; 39: 378–82.
- Voelker R, International group seeks to dispel incontinence “taboo”. JAMA 1998, Sep 16; 280(11): 951–953.
- Nygaard IE, Heit M. Stress urinary incontinence. Obstet Gynecol 2004; 104: 607–20.
- Wilson L, Park GE, Luc KO, Brown JS, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol 2001; 98: 398–406.
- Varmus H. Disease-specific estimates of direct and indirect costs of illness and NIH support. Bethesda (MD): Department of Health and Human Services, National Institute of Health; 1997.
- Ulmstem U et al. The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21(2): 167–178.
- Chapple CR, Artibani W, Cardozo LD, Castro-Diaz D, Craggs M, Haab F, et al. The role of urinary urgency and its measurement in the overactive bladder syndrome: current concepts and future prospects (Review). BJU Int 2005; 95: 335–40.
- Stewart WF, van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–36.
- Irwin D, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 2005; 97: 96–100.
- NICE Clinical Guideline no. 40(2006). Available from www.nice.org.uk/CG 040.
- Bergman A, McCarthy TA, Ballard TA, Yanai J. Role of the Q-tip test in evaluating stress urinary incontinence. J Reprod Med 1987; 32: 273–5.
- Walters MD, Shields MD. The diagnostic value of history, physical examination and the Q-tip cotton swab test in women with urinary incontinence. Am J Obstet Gynecol 1988; 159: 145–9.
- Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC. Duloxetine vs Placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU 2004; 93: 311
- Barber MD, Walters MD, Bump RC. Short forms of two condition specific quality of life questionnaires for women with pelvic floor disorders (PFDI-20 and PF1Q-7). Am J Obstet Gyne (2005); 193: 103–13.